Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,269
+$9,006 QoQ
Shares Held
55
+2650.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#689
of 772 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MANNING & NAPIER ADVISORS LLC holds $28,794,500 across 9 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
1,425,546 | $22,637,670 | |
| 2 | TAK |
Takeda Pharmaceutical Co Ltd
|
206,900 | $3,316,607 | |
| 3 | HLN |
Haleon plc
|
300,561 | $2,804,234 | |
| 4 | ZTS |
Zoetis Inc.
|
239 | $17,174 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
This page
|
55 | $9,269 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
7 | $3,792 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
86 | $2,913 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
38 | $1,767 |
All Filings in NBIX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,269 | 55 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $263 | 2 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $3,120 | 22 | Shares | Sole | 2026-02-03 | |
| No filing history on record for this holder in this stock. | ||||||